225 related articles for article (PubMed ID: 29749580)
1. An economically and environmentally acceptable synthesis of chiral drug intermediate L-pipecolic acid from biomass-derived lysine via artificially engineered microbes.
Cheng J; Huang Y; Mi L; Chen W; Wang D; Wang Q
J Ind Microbiol Biotechnol; 2018 Jun; 45(6):405-415. PubMed ID: 29749580
[TBL] [Abstract][Full Text] [Related]
2. Functional expression of L-lysine α-oxidase from Scomber japonicus in Escherichia coli for one-pot synthesis of L-pipecolic acid from DL-lysine.
Tani Y; Miyake R; Yukami R; Dekishima Y; China H; Saito S; Kawabata H; Mihara H
Appl Microbiol Biotechnol; 2015 Jun; 99(12):5045-54. PubMed ID: 25547835
[TBL] [Abstract][Full Text] [Related]
3. Enzymatic synthesis of L-pipecolic acid by Delta1-piperideine-2-carboxylate reductase from Pseudomonas putida.
Muramatsu H; Mihara H; Yasuda M; Ueda M; Kurihara T; Esaki N
Biosci Biotechnol Biochem; 2006 Sep; 70(9):2296-8. PubMed ID: 16960365
[TBL] [Abstract][Full Text] [Related]
4. Expanding metabolic pathway for de novo biosynthesis of the chiral pharmaceutical intermediate L-pipecolic acid in Escherichia coli.
Ying H; Tao S; Wang J; Ma W; Chen K; Wang X; Ouyang P
Microb Cell Fact; 2017 Mar; 16(1):52. PubMed ID: 28347340
[TBL] [Abstract][Full Text] [Related]
5. An Artificial Pathway for
Luo Z; Wang Z; Wang B; Lu Y; Yan L; Zhao Z; Bai T; Zhang J; Li H; Wang W; Cheng J
Front Microbiol; 2022; 13():842804. PubMed ID: 35350620
[No Abstract] [Full Text] [Related]
6. Metabolic engineering of Escherichia coli for polyamides monomer δ-valerolactam production from feedstock lysine.
Xu Y; Zhou D; Luo R; Yang X; Wang B; Xiong X; Shen W; Wang D; Wang Q
Appl Microbiol Biotechnol; 2020 Dec; 104(23):9965-9977. PubMed ID: 33064187
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of l-Pipecolic Acid Production by Dynamic Control of Substrates and Multiple Copies of the
Xu X; Rao ZM; Xu JZ; Zhang WG
ACS Synth Biol; 2022 Feb; 11(2):760-769. PubMed ID: 35073050
[TBL] [Abstract][Full Text] [Related]
8. An artificial pathway for trans-4-hydroxy-L-pipecolic acid production from L-lysine in Escherichia coli.
Cheng J; Luo Z; Wang B; Yan L; Zhang S; Zhang J; Lu Y; Wang W
Biosci Biotechnol Biochem; 2022 Sep; 86(10):1476-1481. PubMed ID: 35998310
[TBL] [Abstract][Full Text] [Related]
9. Metabolic engineering of Corynebacterium glutamicum for enhanced production of 5-aminovaleric acid.
Shin JH; Park SH; Oh YH; Choi JW; Lee MH; Cho JS; Jeong KJ; Joo JC; Yu J; Park SJ; Lee SY
Microb Cell Fact; 2016 Oct; 15(1):174. PubMed ID: 27717386
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of pipecolic acid production by the expression of multiple lysine cyclodeaminase in the Escherichia coli whole-cell system.
Han YH; Choi TR; Park YL; Park JY; Song HS; Kim HJ; Lee SM; Park SL; Lee HS; Bhatia SK; Gurav R; Yang YH
Enzyme Microb Technol; 2020 Oct; 140():109643. PubMed ID: 32912695
[TBL] [Abstract][Full Text] [Related]
11. Engineering Corynebacterium glutamicum for fast production of L-lysine and L-pipecolic acid.
Pérez-García F; Peters-Wendisch P; Wendisch VF
Appl Microbiol Biotechnol; 2016 Sep; 100(18):8075-90. PubMed ID: 27345060
[TBL] [Abstract][Full Text] [Related]
12. Expanding lysine industry: industrial biomanufacturing of lysine and its derivatives.
Cheng J; Chen P; Song A; Wang D; Wang Q
J Ind Microbiol Biotechnol; 2018 Aug; 45(8):719-734. PubMed ID: 29654382
[TBL] [Abstract][Full Text] [Related]
13. Systems metabolic engineering upgrades Corynebacterium glutamicum for selective high-level production of the chiral drug precursor and cell-protective extremolyte L-pipecolic acid.
Pauli S; Kohlstedt M; Lamber J; Weiland F; Becker J; Wittmann C
Metab Eng; 2023 May; 77():100-117. PubMed ID: 36931556
[TBL] [Abstract][Full Text] [Related]
14. Highly Efficient Production of l-Histidine from Glucose by Metabolically Engineered
Wu H; Tian D; Fan X; Fan W; Zhang Y; Jiang S; Wen C; Ma Q; Chen N; Xie X
ACS Synth Biol; 2020 Jul; 9(7):1813-1822. PubMed ID: 32470291
[TBL] [Abstract][Full Text] [Related]
15. Fermentative production of L-pipecolic acid from glucose and alternative carbon sources.
Pérez-García F; Max Risse J; Friehs K; Wendisch VF
Biotechnol J; 2017 Jul; 12(7):. PubMed ID: 28169491
[TBL] [Abstract][Full Text] [Related]
16. High-efficiency production of 5-aminovalerate in engineered Escherichia coli controlled by an anaerobically-induced nirB promoter.
Cheng J; Tu W; Cao R; Gou X; Zhang Y; Wang D; Li Q
Biochem Biophys Res Commun; 2021 May; 552():170-175. PubMed ID: 33751934
[TBL] [Abstract][Full Text] [Related]
17. Systems metabolic engineering of Corynebacterium glutamicum for the production of the carbon-5 platform chemicals 5-aminovalerate and glutarate.
Rohles CM; Gießelmann G; Kohlstedt M; Wittmann C; Becker J
Microb Cell Fact; 2016 Sep; 15(1):154. PubMed ID: 27618862
[TBL] [Abstract][Full Text] [Related]
18. Metabolic engineering of Escherichia coli for de novo production of 3-phenylpropanol via retrobiosynthesis approach.
Liu Z; Zhang X; Lei D; Qiao B; Zhao GR
Microb Cell Fact; 2021 Jun; 20(1):121. PubMed ID: 34176467
[TBL] [Abstract][Full Text] [Related]
19. Biotransformation of L-lysine to L-pipecolic acid catalyzed by L-lysine 6-aminotransferase and pyrroline-5-carboxylate reductase.
Fujii T; Mukaihara M; Agematu H; Tsunekawa H
Biosci Biotechnol Biochem; 2002 Mar; 66(3):622-7. PubMed ID: 12005058
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances in Microbial Production of
Choi S; Lee HN; Park E; Lee SJ; Kim ES
Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32854378
[No Abstract] [Full Text] [Related]
[Next] [New Search]
